Literature DB >> 31799202

Assessment of Preoperative Liver Function for Surgical Decision Making in Patients with Hepatocellular Carcinoma.

Takashi Kokudo1, Kiyoshi Hasegawa1, Chikara Shirata1, Meguri Tanimoto1, Takeaki Ishizawa1, Junichi Kaneko1, Nobuhisa Akamatsu1, Junichi Arita1, Nicolas Demartines2, Emilie Uldry2, Norihiro Kokudo3, Nermin Halkic2.   

Abstract

BACKGROUND: Most patients with hepatocellular carcinoma (HCC) have underlying liver disease and a preoperative liver function evaluation is important to avoid postoperative liver failure and death. In Western guidelines, portal hypertension (PH) is listed as a contraindication for liver resection. On the other hand, the indocyanine green retention rate at 15 min (ICG R15) has been widely used in Asian countries for surgical decision making. However, these criteria are based on reports published in the 20th century that included only a small number of patients and were developed empirically.
SUMMARY: The number of published case series concerning liver resection in HCC patients with PH has been rapidly increasing since 2011, indicating that liver resection in HCC patients with PH is now routinely performed in specialized centers worldwide. Although PH certainly has an impact and should be considered as a contraindication for major liver resection, it is no longer considered to be a contraindication for minor liver resection, especially laparoscopic liver resection. In addition, new biomarkers and imaging tools to assess preoperative liver function have been extensively reported. The combination of these new factors to well-known risk factors, such as PH and ICG R15, might strengthen the ability to stratify the risk of postoperative liver failure. KEY MESSAGES: The present review covers recent topics regarding the assessment of preoperative liver function for surgical decision making in patients with HCC.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  Hepatocellular carcinoma; Indocyanine green; Portal hypertension

Year:  2019        PMID: 31799202      PMCID: PMC6883438          DOI: 10.1159/000501368

Source DB:  PubMed          Journal:  Liver Cancer        ISSN: 1664-5553            Impact factor:   11.740


  51 in total

Review 1.  Strategies for safer liver surgery and partial liver transplantation.

Authors:  Pierre-Alain Clavien; Henrik Petrowsky; Michelle L DeOliveira; Rolf Graf
Journal:  N Engl J Med       Date:  2007-04-12       Impact factor: 91.245

2.  Hepatobiliary scintigraphy to evaluate liver function in associating liver partition and portal vein ligation for staged hepatectomy: Liver volume overestimates liver function.

Authors:  Pim B Olthof; Federico Tomassini; Pablo E Huespe; Stephanie Truant; François-René Pruvot; Roberto I Troisi; Carlos Castro; Erik Schadde; Rimma Axelsson; Ernesto Sparrelid; Roelof J Bennink; Rene Adam; Thomas M van Gulik; Eduardo de Santibanes
Journal:  Surgery       Date:  2017-07-18       Impact factor: 3.982

3.  Indication of hepatectomy for cirrhotic patients with hepatocellular carcinoma classified as Child-Pugh class B.

Authors:  Hideki Nakahara; Toshiyuki Itamoto; Koji Katayama; Hideki Ohdan; Hiroshi Hino; Makoto Ochi; Hirotaka Tashiro; Toshimasa Asahara
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

4.  Selection criteria for hepatectomy in patients with hepatocellular carcinoma classified as Child-Pugh class B.

Authors:  Shintaro Kuroda; Hirotaka Tashiro; Tsuyoshi Kobayashi; Akihiko Oshita; Hironobu Amano; Hideki Ohdan
Journal:  World J Surg       Date:  2011-04       Impact factor: 3.352

5.  The impact of chronic liver disease on the risk assessment of ACS NSQIP morbidity and mortality after hepatic resection.

Authors:  Victor M Zaydfudim; Matthew J Kerwin; Florence E Turrentine; Todd W Bauer; Reid B Adams; George J Stukenborg
Journal:  Surgery       Date:  2015-12-31       Impact factor: 3.982

6.  Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors.

Authors:  K Kubota; M Makuuchi; K Kusaka; T Kobayashi; K Miki; K Hasegawa; Y Harihara; T Takayama
Journal:  Hepatology       Date:  1997-11       Impact factor: 17.425

7.  A new formula for calculating standard liver volume for living donor liver transplantation without using body weight.

Authors:  Takashi Kokudo; Kiyoshi Hasegawa; Emilie Uldry; Yutaka Matsuyama; Junichi Kaneko; Nobuhisa Akamatsu; Taku Aoki; Yoshihiro Sakamoto; Nicolas Demartines; Yasuhiko Sugawara; Norihiro Kokudo; Nermin Halkic
Journal:  J Hepatol       Date:  2015-06-06       Impact factor: 25.083

8.  Safe hepatectomy selection criteria for hepatocellular carcinoma patients: a validation of 336 consecutive hepatectomies. The BILCHE score.

Authors:  Matteo Donadon; Guido Costa; Matteo Cimino; Fabio Procopio; Daniele Del Fabbro; Angela Palmisano; Guido Torzilli
Journal:  World J Surg       Date:  2015-01       Impact factor: 3.352

9.  2012 Liver resections in the 21st century: we are far from zero mortality.

Authors:  Safi Dokmak; Fadhel Samir Ftériche; René Borscheid; François Cauchy; Olivier Farges; Jacques Belghiti
Journal:  HPB (Oxford)       Date:  2013-03-06       Impact factor: 3.647

10.  Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality.

Authors:  Swee H Teh; John Christein; John Donohue; Florencia Que; Michael Kendrick; Michael Farnell; Stephen Cha; Patrick Kamath; Raymond Kim; David M Nagorney
Journal:  J Gastrointest Surg       Date:  2005-12       Impact factor: 3.267

View more
  10 in total

1.  Diabetes mellitus and postoperative blood glucose value help predict posthepatectomy liver failure in patients with hepatocellular carcinoma.

Authors:  Jianchen Luo; Liangliang Xu; Lian Li; Jingfu Zhang; Ming Zhang; Mingqing Xu
Journal:  J Gastrointest Oncol       Date:  2021-10

2.  Interventional real-time optical imaging guidance for complete tumor ablation.

Authors:  Xuefeng Kan; Feng Zhang; Guanhui Zhou; Hongxiu Ji; Wayne Monsky; Christopher Ingraham; Chuansheng Zheng; Xiaoming Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-12       Impact factor: 11.205

3.  A detailed assessment of liver function in patients with hepatocellular carcinoma via the modified albumin-bilirubin (mALBI) grade.

Authors:  Cheng-Rui Zhong; Ji-Liang Qiu; Yi-Chuan Yuan; Zhi-Yu Qiu; Kai Li; Chen-Wei Wang; Yun-Xing Shi; Ke-Ren Li; Zhu Lin; Zhen-Kun Huang; Wei He; Bin-Kui Li; Yun-Fei Yuan
Journal:  Am J Cancer Res       Date:  2022-06-15       Impact factor: 5.942

Review 4.  Noninvasive imaging of hepatic dysfunction: A state-of-the-art review.

Authors:  Ting Duan; Han-Yu Jiang; Wen-Wu Ling; Bin Song
Journal:  World J Gastroenterol       Date:  2022-04-28       Impact factor: 5.374

5.  Comparative study of indocyanine green (ICG)-R15 and Albumin-Indocyanine Green Evaluation (ALICE) grading system in the prediction of posthepatectomy liver failure and postoperative mortality in patients with hepatic alveolar echinococcosis.

Authors:  Yuxin Liang; Zilong Zhang; Zonglin Dai; Rui Cao; Deyuan Zhong; Chunyou Lai; Yutong Yao; Tianhang Feng; Xiaolun Huang
Journal:  BMC Gastroenterol       Date:  2022-06-14       Impact factor: 2.847

Review 6.  Prognostic role of preoperative albumin-bilirubin score in posthepatectomy liver failure and mortality: a systematic review and meta-analysis.

Authors:  Shuai Zhou; Shuangchi Liu; Huichun Liu; Qing Pang; Zheng Lu
Journal:  Updates Surg       Date:  2021-05-19

7.  Extracellular Polysaccharide from Rhizopus nigricans Inhibits Hepatocellular Carcinoma via miR-494-3p/TRIM36 Axis and Cyclin E Ubiquitination.

Authors:  Haixiong Yan; XiaoQian Ma; Ze Mi; Zhenhu He; Pengfei Rong
Journal:  J Clin Transl Hepatol       Date:  2022-02-21

8.  Usefulness of the estimation of physiologic ability and surgical stress (E-PASS) system for prediction of complication and prognosis in hepatocellular carcinoma patients after hepatectomy.

Authors:  Yili Dai; Guoqiao Chen; Yongle Chen; Zhaoqi Shi; Junhai Pan; Xiaoxiao Fan; Hui Lin
Journal:  Transl Cancer Res       Date:  2022-08       Impact factor: 0.496

9.  Comment on "Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis".

Authors:  Xiao-Long Tang; Yan-Dong Miao; Deng-Hai Mi
Journal:  World J Gastrointest Oncol       Date:  2022-01-15

10.  A novel preoperative predictive model of 90-day mortality after liver resection for huge hepatocellular carcinoma.

Authors:  Yue Yin; Jian-Wen Cheng; Fei-Yu Chen; Xu-Xiao Chen; Xin Zhang; Ao Huang; De-Zhen Guo; Yu-Peng Wang; Ya Cao; Jia Fan; Jian Zhou; Xin-Rong Yang
Journal:  Ann Transl Med       Date:  2021-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.